Lentiviral Gene Therapies Market Size, Share & Industry Analysis, By Product (Skysona, Lyfgenia, Zynteglo, Libmeldy, and Others), By Delivery Method (Ex-vivo and In-vivo), By Disease Indication (Β-Thalassemia, Cerebral Adrenoleukodystrophy (CALD), Metachromatic Leukodystrophy (MLD), Sickle Cell Disease, and Others), By End User (Hospitals & Clinics, Specialty Clinics, and Others), and Regional Forecast, 2026-2034

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

Schedule a 30 minutes session to understand our consulting capabilities – SCHEDULE NOW

Table of Content:

1. Introduction
   1. Market Scope
   2. Market Segmentation
   3. Market Methodology
   4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
   1. Market Drivers
   2. Market Restraints
   3. Market Opportunities
   4. Market Trends
4. Key Insights
   1. Regulatory Scenarios, By Key Countries/Regions
   2. Overview of Technological Advancements in the Lentiviral Gene Therapies
   3. New Product Launches, By Key Players
   4. Pipeline Analysis, By Key Companies
   5. Key Industry Developments (Mergers, Acquisitions, Partnerships, Launches, and Others)
   6. Investment & Funding Trends in the Market
5. Global Lentiviral Gene Therapies Market Analysis, Insights and Forecast, 2019-2032
   1. Market Analysis, Insights and Forecast – By Product
      1. Skysona
      2. Lyfgenia
      3. Zynteglo
      4. Libmeldy
      5. Others
   2. Market Analysis, Insights and Forecast – By Delivery Method
      1. Ex vivo
      2. In vivo
   3. Market Analysis, Insights and Forecast – By Disease Indication
      1. Β-Thalassemia
      2. Cerebral Adrenoleukodystrophy (CALD)
      3. Metachromatic Leukodystrophy (MLD)
      4. Sickle Cell Disease
      5. Others
   4. Market Analysis, Insights and Forecast – By End User
      1. Hospitals & Clinics
      2. Specialty Clinics
      3. Others
   5. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
6. North America Lentiviral Gene Therapies Market Analysis, Insights and Forecast, 2019-2032
   1. Market Analysis, Insights and Forecast – By Product
      1. Skysona
      2. Lyfgenia
      3. Zynteglo
      4. Libmeldy
      5. Others
   2. Market Analysis, Insights and Forecast – By Delivery Method
      1. Ex vivo
      2. In vivo
   3. Market Analysis, Insights and Forecast – By Disease Indication
      1. Β-Thalassemia
      2. Cerebral Adrenoleukodystrophy (CALD)
      3. Metachromatic Leukodystrophy (MLD)
      4. Sickle Cell Disease
      5. Others
   4. Market Analysis, Insights and Forecast – By End User
      1. Hospitals & Clinics
      2. Specialty Clinics
      3. Others
   5. Market Analysis, Insights and Forecast – By Country
      1. U.S.
      2. Canada
7. Europe Lentiviral Gene Therapies Market Analysis, Insights and Forecast, 2019-2032
   1. Market Analysis, Insights and Forecast – By Product
      1. Skysona
      2. Lyfgenia
      3. Zynteglo
      4. Libmeldy
      5. Others
   2. Market Analysis, Insights and Forecast – By Delivery Method
      1. Ex vivo
      2. In vivo
   3. Market Analysis, Insights and Forecast – By Disease Indication
      1. Β-Thalassemia
      2. Cerebral Adrenoleukodystrophy (CALD)
      3. Metachromatic Leukodystrophy (MLD)
      4. Sickle Cell Disease
      5. Others
   4. Market Analysis, Insights and Forecast – By End User
      1. Hospitals & Clinics
      2. Specialty Clinics
      3. Others
   5. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. U.K.
      2. Germany
      3. France
      4. Spain
      5. Italy
      6. Scandinavia
      7. Rest of Europe
8. Asia Pacific Lentiviral Gene Therapies Market Analysis, Insights and Forecast, 2019-2032
   1. Market Analysis, Insights and Forecast – By Product
      1. Skysona
      2. Lyfgenia
      3. Zynteglo
      4. Libmeldy
      5. Others
   2. Market Analysis, Insights and Forecast – By Delivery Method
      1. Ex vivo
      2. In vivo
   3. Market Analysis, Insights and Forecast – By Disease Indication
      1. Β-Thalassemia
      2. Cerebral Adrenoleukodystrophy (CALD)
      3. Metachromatic Leukodystrophy (MLD)
      4. Sickle Cell Disease
      5. Others
   4. Market Analysis, Insights and Forecast – By End User
      1. Hospitals & Clinics
      2. Specialty Clinics
      3. Others
   5. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. Japan
      2. China
      3. India
      4. Southeast Asia
      5. Rest of Asia Pacific
9. Latin America Lentiviral Gene Therapies Market Analysis, Insights and Forecast, 2019-2032
   1. Market Analysis, Insights and Forecast – By Product
      1. Skysona
      2. Lyfgenia
      3. Zynteglo
      4. Libmeldy
      5. Others
   2. Market Analysis, Insights and Forecast – By Delivery Method
      1. Ex vivo
      2. In vivo
   3. Market Analysis, Insights and Forecast – By Disease Indication
      1. Β-Thalassemia
      2. Cerebral Adrenoleukodystrophy (CALD)
      3. Metachromatic Leukodystrophy (MLD)
      4. Sickle Cell Disease
      5. Others
   4. Market Analysis, Insights and Forecast – By End User
      1. Hospitals & Clinics
      2. Specialty Clinics
      3. Others
   5. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. Brazil
      2. Mexico
      3. Rest of Latin America
10. Middle East & Africa Lentiviral Gene Therapies Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Product
       1. Skysona
       2. Lyfgenia
       3. Zynteglo
       4. Libmeldy
       5. Others
    2. Market Analysis, Insights and Forecast – By Delivery Method
       1. Ex vivo
       2. In vivo
    3. Market Analysis, Insights and Forecast – By Disease Indication
       1. Β-Thalassemia
       2. Cerebral Adrenoleukodystrophy (CALD)
       3. Metachromatic Leukodystrophy (MLD)
       4. Sickle Cell Disease
       5. Others
    4. Market Analysis, Insights and Forecast – By End User
       1. Hospitals & Clinics
       2. Specialty Clinics
       3. Others
    5. Market Analysis, Insights and Forecast – By Country/Sub-region
       1. South Africa
       2. GCC
       3. Rest of the Middle East & Africa
11. Competitive Analysis
    1. Global Market Share Analysis (2024)
    2. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
       1. ELIXI International SA
       2. Stevenage Bioscience Catalyst
       3. VIVEbiotech
       4. Oxford Biomedica
       5. Miltenyi Biotec
       6. Genetix Biotherapeutics
       7. Boehringer Ingelheim International GmbH.
       8. Orchard Therapeutics plc